Pancreatic Neoplasms
Showing NaN - NaN of 11
Chromogranin A as Blood Marker in Cancer Patients
Completed
- Gastric Neoplasms
- +3 more
- BRAHMS CgA II KRYPTOR
-
Palo Alto, California
- +3 more
Dec 19, 2022
Pancreatic Tumors Trial in Worldwide (hMN14 (labetuzumab))
Completed
- Pancreatic Neoplasms
- hMN14 (labetuzumab)
-
Newport Beach, California
- +9 more
Aug 12, 2021
Bowel Obstruction, Bowel Ischemia, Diverticulitis Trial in Berlin (ICG-NIRF Imaging plus ingress and egress analysis)
Recruiting
- Bowel Obstruction
- +11 more
- ICG-NIRF Imaging plus ingress and egress analysis
-
Berlin, GermanyCharité Campus Benjamin Franklin
Jan 13, 2021
Pancreatic Tumors, Cholestasis Trial in Germany, United States (nab-paclitaxel, Gemcitabine)
Terminated
- Pancreatic Neoplasms
- Cholestasis
-
Scottsdale, Arizona
- +5 more
Oct 30, 2019
Pancreatic Tumors Trial in Worldwide (Gemcitabine, AG-013736)
Completed
- Pancreatic Neoplasms
-
Antioch, California
- +37 more
Apr 22, 2019
Pancreatic Tumors, Melanoma, Colorectal Tumors Trial in Germany (AP 12009)
Completed
- Pancreatic Neoplasms
- +2 more
- AP 12009
-
Berlin, Germany
- +9 more
Feb 13, 2019
Pancreatic Tumors Trial in Worldwide (LY2603618, Gemcitabine)
Completed
- Pancreatic Neoplasms
-
Jacksonville, Florida
- +29 more
Mar 15, 2018
Pancreatic Tumors Trial in Worldwide (Larotaxel (XRP9881), 5-Fluorouracil, Capecitabine)
Completed
- Pancreatic Neoplasms
- Larotaxel (XRP9881)
- +2 more
-
Bridgewater, New Jersey
- +20 more
May 3, 2016
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013